AMPLIFY - D6571C00001 Duaklir USA Phase III Study (Q66402163)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AMPLIFY - D6571C00001 Duaklir USA Phase III Study |
clinical trial |
Statements
A 24 Week Treatment, Multicenter, Randomized, Double Blinded, Double Dummy, Parallel-group, Clinical Trial Evaluating the Efficacy and Safety of Aclidinium Bromide 400 μg/Formoterol Fumarate 12 μg Fixed-dose Combination BID Compared With Each Monotherapy (Aclidinium Bromide 400 μg BID and Formoterol Fumarate 12 μg BID) and Tiotropium 18 μg QD When Administered to Patients With Stable Chronic Obstructive Pulmonary Disease. (English)
0 references
5 July 2016
0 references
8 June 2017
0 references
1,595
0 references
40 year
0 references
130 year
0 references